Page last updated: 2024-09-05

tak 779 and lamivudine

tak 779 has been researched along with lamivudine in 3 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(lamivudine)
Trials
(lamivudine)
Recent Studies (post-2010) (lamivudine)
1181357,0251,4252,177

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)lamivudine (IC50)
Capsid protein Hepatitis B virus0.1

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ariƫn, KK; Arts, EJ; Colebunders, RL; Gali, Y; Troyer, RM; Vanham, G1
Heil, M; Jones, J; Kutsch, O; Ochsenbauer-Jambor, C; Zammit, KP1
Arts, EJ; Lobritz, MA; Marozsan, AJ; Troyer, RM1

Other Studies

3 other study(ies) available for tak 779 and lamivudine

ArticleYear
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.
    AIDS (London, England), 2005, Oct-14, Volume: 19, Issue:15

    Topics: Amides; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Dendritic Cells; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Phylogeny; Quaternary Ammonium Compounds; Viral Load; Virulence; Virus Replication

2005
T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication.
    BioTechniques, 2006, Volume: 40, Issue:1

    Topics: Amides; Anti-HIV Agents; Biomarkers; CCR5 Receptor Antagonists; Cell Culture Techniques; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Fusion Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Microscopy, Fluorescence; Quaternary Ammonium Compounds; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Virus Replication

2006
Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity.
    Journal of virology, 2007, Volume: 81, Issue:15

    Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Chemokine CCL5; Drug Resistance, Viral; Genetic Variation; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Lamivudine; Macrophages; Models, Molecular; Peptide Fragments; Protein Structure, Tertiary; Quaternary Ammonium Compounds; Receptors, CCR5; Virus Replication

2007